Pharmafile Logo
Pharmafocus logo
Advanced Search

Eli Lilly’s diabetes treatment wins FDA approval

May 16, 2022
Sales and Marketing

Eli Lilly’s once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide has won FDA approval.The FDA …

News

NHS prescription charges in England to be frozen for first time in 12 years

May 16, 2022
Sales and Marketing

The Department of Health has said that single prescription charges, which normally rise “in line with inflation”, will remain at …

News

Imfimzi for routine use on NHS England for patients with stage III unresectable lung cancer

May 16, 2022
Sales and Marketing

AstraZeneca has announced the NICE recommendation of Imfinzi (durvalumab) for routine use within NHS England as a monotherapy for the …

News

Researchers pinpoint reason for Sudden Infant Deaths

May 16, 2022
Sales and Marketing

Scientists from The Children’s Hospital Westmead in Sydney have discovered that babies who died of sudden infant death syndrome (SIDS) …

News

60,000 NHS staff believed to suffer pandemic-related PTSD

May 13, 2022
Medical Communications

As many as 60,000 NHS staff are believed to be suffering from post-traumatic stress brought on by the COVID-19 pandemic, …

News

New national guidance addressing sepsis

May 13, 2022
Medical Communications

New guidelines proposing significant changes to the way people with suspected sepsis are treated with antibiotics have been published. The …

News

Plant-based COVID-19 vaccine demonstrates 70% efficacy

May 12, 2022
Business Services

The vaccine was developed by researchers at Canadian biotechnology company Medicago, and it contains coronavirus-like particles (CoVLP) produced in plants, …

News

Hypertensive pregnancy disorders linked to future cardiac events

May 12, 2022
Business Services

A study funded by the US National Institutes of Health (NIH) has explained factors linked to increased risk for heart …

News

Phase III trial reveals positive results for Crohn’s disease treatment

May 12, 2022
Business Services

AbbVie has announced positive topline results from U-ENDURE, its Phase III maintenance study, evaluating upadacitinib in adult patients with Crohn’s …

News

FDA approve Lilly-Incyte’s treatment for hospitalised COVID patients

May 12, 2022
Business Services

The FDA has granted approval for Eli Lilly and Incyte’s Olumiant (baricitinib) to treat COVID-19 in adult patients admitted to …

News

SMC accepts chemotherapy-free VENCLYXTO for leukaemia treatment

May 11, 2022
Research and Development

The SMC has accepted venetoclax in combination with obinutuzumab, for use within NHS Scotland, as a first-line treatment for patients …

News

Europe’s first psychedelic drug trial clinic to open in London

May 11, 2022
Research and Development

British startup Clerkenwell Health aims to make the UK a global leader in psychedelic research and innovation, with Europe’s first …

News

Partnership researching genetics and treatments of long COVID

May 11, 2022
Research and Development

PrecisionLife Limited have announced a partnership with Sano Genetics, a genetic research platform enabling patients to participate in ethical research …

News

Ardena confirms spray drying upgrade and other capabilities at Spanish site

May 11, 2022
Research and Development

 

News

WHO delivers 20 ambulances to Ukraine

May 10, 2022
Manufacturing and Production

In efforts to support emergency health needs in Ukraine, WHO have given 20 all-terrain ambulances able to function in even …

News

MGC Pharma receives patent protection for epilepsy drug

May 10, 2022
Manufacturing and Production

MGC Pharmaceuticals said a patent had been granted, protecting its unique system used to deliver a cannabis-derived drug being developed …

News

Fourth-dose COVID-19 jab demonstrates good boost

May 10, 2022
Manufacturing and Production

A UK trial has revealed that fourth-dose COVID-19 booster vaccines increase protection against the disease, particularly those aged over 70. …

News

NIH discovery could advance precise therapies for blinding diseases

May 10, 2022
Manufacturing and Production

Research at the National Institutes of Health (NIH) have identified distinct differences among the cells comprising a tissue in the …

News

Evofem’s Phase III trial reveals fewer UTIs in women using Phexxi

May 9, 2022
Sales and Marketing

Evofem has announced new data from the Phase III AMPOWER clinical trial of Phexxi (lactic acid, citric acid, and potassium …

News

NIH launches clinical trial of vaccine for Epstein-Barr virus

May 9, 2022
Research and Development

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched an …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026